Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Addition of estimated cardiorespiratory fitness to the clinical assessment of 10-year coronary heart disease risk in asymptomatic men.

Gander JC, Sui X, Hébert JR, Lavie CJ, Hazlett LJ, Cai B, Blair SN.

Prev Med Rep. 2017 May 18;7:30-37. doi: 10.1016/j.pmedr.2017.05.008. eCollection 2017 Sep.

2.

Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study.

Menon VP, Edathadathil F, Sathyapalan D, Moni M, Don A, Balachandran S, Pushpa B, Prasanna P, Sivaram N, Nair A, Vinod N, Jayaprasad R, Menon V.

Medicine (Baltimore). 2016 Dec;95(49):e5542.

3.

The Role of a Coronary Artery Calcium Scan in Type 1 Diabetes.

Burge MR, Eaton RP, Schade DS.

Diabetes Technol Ther. 2016 Sep;18(9):594-603. doi: 10.1089/dia.2016.0110. Epub 2016 Sep 1.

4.

Coronary artery calcium screening: does it perform better than other cardiovascular risk stratification tools?

Zeb I, Budoff M.

Int J Mol Sci. 2015 Mar 23;16(3):6606-20. doi: 10.3390/ijms16036606. Review.

5.

Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis.

Miedema MD, Duprez DA, Misialek JR, Blaha MJ, Nasir K, Silverman MG, Blankstein R, Budoff MJ, Greenland P, Folsom AR.

Circ Cardiovasc Qual Outcomes. 2014 May;7(3):453-60. doi: 10.1161/CIRCOUTCOMES.113.000690. Epub 2014 May 6.

6.

Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Brooks MM, Chaitman BR, Nesto RW, Hardison RM, Feit F, Gersh BJ, Krone RJ, Sako EY, Rogers WJ, Garber AJ, King SB 3rd, Davidson CJ, Ikeno F, Frye RL; BARI 2D Study Group.

Circulation. 2012 Oct 23;126(17):2115-24. doi: 10.1161/CIRCULATIONAHA.112.092973. Epub 2012 Sep 24.

7.

Usefulness of the left ventricular myocardial contraction fraction in healthy men and women to predict cardiovascular morbidity and mortality.

Chuang ML, Gona P, Salton CJ, Yeon SB, Kissinger KV, Blease SJ, Levy D, O'Donnell CJ, Manning WJ.

Am J Cardiol. 2012 May 15;109(10):1454-8. doi: 10.1016/j.amjcard.2012.01.357. Epub 2012 Feb 28.

8.

Sex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart disease.

Laughlin GA, McEvoy LK, von Mühlen D, Daniels LB, Kritz-Silverstein D, Bergstrom J, Cummins K, Der-Martirosian C, Jassal SK, Barrett-Connor E.

Psychosom Med. 2011 Oct;73(8):683-9. doi: 10.1097/PSY.0b013e31822f9089. Epub 2011 Sep 23.

9.

Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study).

Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, Di Tullio MR, Homma S, Elkind MS, Paik MC.

J Am Coll Cardiol. 2009 Dec 8;54(24):2303-11. doi: 10.1016/j.jacc.2009.07.047.

10.

Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study).

Hoffmann U, Massaro JM, Fox CS, Manders E, O'Donnell CJ.

Am J Cardiol. 2008 Nov 1;102(9):1136-41, 1141.e1. doi: 10.1016/j.amjcard.2008.06.038. Epub 2008 Aug 20.

11.

Migraine, vascular risk, and cardiovascular events in women: prospective cohort study.

Kurth T, Schürks M, Logroscino G, Gaziano JM, Buring JE.

BMJ. 2008 Aug 7;337:a636. doi: 10.1136/bmj.a636.

12.

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.

Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d'Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM.

JAMA. 2008 Jul 9;300(2):197-208. doi: 10.1001/jama.300.2.197. Review.

13.

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P.

BMJ. 2008 Jun 28;336(7659):1475-82. doi: 10.1136/bmj.39609.449676.25. Epub 2008 Jun 23.

14.

Expert review on coronary calcium.

Budoff MJ, Gul KM.

Vasc Health Risk Manag. 2008;4(2):315-24. Review.

15.

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P.

BMJ. 2007 Jul 21;335(7611):136. Epub 2007 Jul 5.

16.

Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.

Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, Ebrahim S.

BMJ. 2003 Nov 29;327(7426):1267.

Supplemental Content

Loading ...
Support Center